Efficacy and Safety of Chemotherapy Following Anti-PD-1 Antibody Therapy for Gastric Cancer: A Case of Sclerosing Cholangitis. [electronic resource]
Producer: 20190708Description: 1263-1266 p. digitalISSN:- 1349-7235
- Adenocarcinoma -- drug therapy
- Albumins -- administration & dosage
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cholangitis, Sclerosing -- chemically induced
- Female
- Humans
- Immunotherapy -- adverse effects
- Middle Aged
- Nivolumab -- administration & dosage
- Paclitaxel -- administration & dosage
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Stomach Neoplasms -- drug therapy
- Ramucirumab
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.